The March 25 decision by the California Board of Pharmacy to push back the state's e-Pedigree deadline by two years (its second two-year delay) gives the overwhelming majority of the pharmaceutical companies in the U.S. new breathing room to meet thernanti-counterfeiting measures laid out by the Golden State. But those same foot-draggers, who pushed first in 2005 for an e-Pedigree delay to January 1, 2009, and again for another delay to January 1, 2011, now are at risk for being awarded the Black Hat worn by bad guys. That allows the very small handful of companies who have solved the packaging serialization puzzle to claim the competitive and public relations benefits that come to those who wear the White Hats.
展开▼
